C12N2740/10011 - CPC Classification Index

ClassID:

110266 ⎘

C12N2740/10011 - CPC Classification

Classification description:

Reverse transcribing RNA viruses; Details Retroviridae

Sub-classes:

C12N2740/10021 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 11
C12N2740/10022 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 87
C12N2740/10023 » Virus like particles [VLP] 29
C12N2740/10031 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 0
C12N2740/10032 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 7
C12N2740/10033 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 6
C12N2740/10034 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 25
C12N2740/10041 » Use of virus, viral particle or viral elements as a vector 40
C12N2740/10051 » Methods of production or purification of viral material 24
C12N2740/10061 » Methods of inactivation or attenuation 1
C12N2740/10071 » Demonstrated in vivo effect 16
C12N2740/10088 » For redistribution 0
C12N2740/11011 » Alpharetrovirus, e.g. avian leucosis virus 6
C12N2740/12011 » Betaretrovirus, e.g. mouse mammary tumour virus 0
C12N2740/13011 » Gammaretrovirus, e.g. murine leukeamia virus 9
C12N2740/14011 » Deltaretrovirus, e.g. bovine leukeamia virus 2
C12N2740/15011 » Lentivirus, not HIV, e.g. FIV, SIV 32
C12N2740/16011 » Human Immunodeficiency Virus, HIV 102
C12N2740/17011 » Spumavirus, e.g. chimpanzee foamy virus 0

Recent Application in this class:

20220307014

2022-09-29

Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells via viral delivery

20220145327

2022-05-12

Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells via viral delivery

20210332389

2021-10-28

Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells using microcarriers

20210332352

2021-10-28

Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells via viral delivery

20200308258

2020-10-01

Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelope protein in patients with sporadic amyotrophic lateral sclerosis

20200140527

2020-05-07

Human monoclonal antibodies to human endogenous retrovirus K envelope (HERV-K) and use thereof

20190345232

2019-11-14

Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody

20190263895

2019-08-29

Antiretroviral drug targeting human endogenous retrovirus

20190192654

2019-06-27

Microparticulated Vaccines for the Oral or Nasal Vaccination and Boostering of Animals Including Fish

#10

20170369558

2017-12-28

Neutralizing antibodies to HIV-1 and their use

#11

20160222473

2016-08-04

Compositions and methods for the identification of inhibitors of retroviral infection

#12

20160009789

2016-01-14

Neutralizing antibodies to HIV-1 and their use

#13

20140121124

2014-05-01

Compositions and methods for the identification of inhibitors of retroviral infection

#14

20140099324

2014-04-10

HERV-K antigens, antibodies, and methods

#15

20120282264

2012-11-08

Neutralizing antibodies to HIV-1 and their use

#16

20120244166

2012-09-27

NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE

#17

20120237523

2012-09-20

Neutralizing antibodies to HIV-1 and their use

#18

20120040010

2012-02-16

Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish

#19

20110033850

2011-02-10

COMPOSITIONS AND METHODS FOR THE IDENTIFICATION OF INHIBITORS OF RETROVIRAL INFECTION

#20

20110008770

2011-01-13

COMPOSITIONS AND METHODS FOR REVERSE TRANSCRIPTION OF NUCLEIC ACID MOLECULES

#21

20100291032

2010-11-18

COMPOSITIONS AND METHODS FOR THE IDENTIFICATION OF INHIBITORS OF RETROVIRAL INFECTION

#22

20090297530

2009-12-03

HERV-K ANTIGENS, ANTIBODIES, AND METHODS

#23

20080152625

2008-06-26

Swine population having low levels of porcine endogenous retrovirus and uses thereof

#24

20070269878

2007-11-22

COMPOSITIONS AND METHODS FOR REVERSE TRANSCRIPTION OF NUCLEIC ACID MOLECULES

#25

20050158724

2005-07-21

Methods, of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof